Pages that link to "Q34486845"
Jump to navigation
Jump to search
The following pages link to Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway (Q34486845):
Displaying 50 items.
- Wnt signaling pathways in urological cancers: past decades and still growing (Q21245761) (← links)
- Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma (Q24632246) (← links)
- Wnt Signaling in Renal Cell Carcinoma (Q26744312) (← links)
- Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives (Q26771263) (← links)
- Genetic polymorphism in extracellular regulators of Wnt signaling pathway (Q26862695) (← links)
- Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28 (Q26991723) (← links)
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice (Q28312170) (← links)
- Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor (Q33688573) (← links)
- Differential regulation of growth-promoting signalling pathways by E-cadherin (Q33737721) (← links)
- Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas (Q33777301) (← links)
- Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. (Q33798113) (← links)
- Evidence for altered Wnt signaling in psoriatic skin. (Q33915311) (← links)
- Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study. (Q34084289) (← links)
- Urothelial carcinoma: stem cells on the edge (Q34092411) (← links)
- Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis (Q34181789) (← links)
- Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation (Q34441297) (← links)
- WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors (Q34591481) (← links)
- β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation. (Q34603174) (← links)
- Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. (Q34698294) (← links)
- Signaling pathways in renal cell carcinoma (Q34978827) (← links)
- Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis (Q35006427) (← links)
- A Wnt survival guide: from flies to human disease. (Q35073590) (← links)
- The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence (Q35085317) (← links)
- TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma (Q35273414) (← links)
- Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway (Q35444274) (← links)
- WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix (Q35479045) (← links)
- Alterations in DNA methylation may be the key to early detection and treatment of schistosomal bladder cancer (Q35652549) (← links)
- Bladder cancer: a simple model becomes complex (Q36108115) (← links)
- High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinoma. (Q36244287) (← links)
- Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway (Q36375138) (← links)
- Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma (Q36402322) (← links)
- Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays (Q36614678) (← links)
- Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas (Q36634023) (← links)
- Mining the Wnt pathway for cancer therapeutics (Q36670448) (← links)
- Association between Wnt inhibitory factor-1 expression levels in articular cartilage and the disease severity of patients with osteoarthritis of the knee (Q36741036) (← links)
- T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cells (Q36765065) (← links)
- Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/β-catenin-dependent pathway in vitro and in vivo (Q36839010) (← links)
- Knockdown of TC-1 enhances radiosensitivity of non-small cell lung cancer via the Wnt/β-catenin pathway (Q36961435) (← links)
- The c-myc promoter: still MysterY and challenge (Q37013896) (← links)
- Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium (Q37215956) (← links)
- Epigenetics in bladder cancer (Q37243940) (← links)
- CpG island methylator phenotype predicts progression of malignant melanoma (Q37245444) (← links)
- WIF1 causes dysfunction of heart in transgenic mice (Q37330742) (← links)
- β-Catenin Expression Negatively Correlates with WIF1 and Predicts Poor Clinical Outcomes in Patients with Cervical Cancer (Q37397014) (← links)
- Hypomethylating Agents for Urologic Cancers (Q37854737) (← links)
- The complex roles of Wnt antagonists in RCC. (Q37949269) (← links)
- Hypermethylation in bladder cancer: biological pathways and translational applications (Q37978544) (← links)
- Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway (Q37993742) (← links)
- Exploring molecular genetics of bladder cancer: lessons learned from mouse models (Q37994164) (← links)
- Wnt signaling in castration-resistant prostate cancer: implications for therapy (Q38241850) (← links)